ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-u...
NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translati...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, makes pharmaceutical and biopharmaceutical analysis faster and simp...
Agilent Technologies Inc. announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demon...
Colossal, the world’s first de-extinction company, today announces progress on its ancient DNA agenda and a go-forward vision to enable critical new ...
Designed to run seamlessly on the BioCode® MDx-3000 system, this multiplex nucleic acid amplification test delivers unparalleled accuracy in id...
FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...
Observation: ACROBiosystems' relentless commitment to innovation and strategic partnerships underscores its pivotal role in advancing organoid research and...
Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace® nanoparticle technology in pat...
Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-re...
UroGen Pharma has initiated legal proceedings against pharmaceutical giant Teva over what they're dubbing as "Totally Mundane" Cancer Treatment Patents. Ur...
Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ –...
Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...
Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...
© 2025 Biopharma Boardroom. All Rights Reserved.
